Pharma & Biotech

First reported Oct 24 2014 - Updated 10 hours ago - 12 reports

WHO: Ebola cases pass 10,000 mark

The number of cases in the Ebola outbreak has exceeded 10,000, with 4,922 deaths, the World Health Organization (WHO) says in its latest report.Only 27 of the cases have occurred outside the three worst-hit countries, Sierra Leone, Liberia and Guinea. ... [Published Dhaka Tribune - 10 hours ago]
First reported Oct 24 2014 - Updated Oct 25 2014 - 9 reports

Shire CEO Ornskov 'dumbfounded’ by collapse of AbbVie deal

Shire PLC Chief Executive Officer Flemming Ornskov was preparing for a meeting in Chicago on the integration of his company with AbbVie Inc. when he got the news that AbbVie was reconsidering the $52 billion takeover.“We were as dumbfounded as anyone ... [Published San Francisco Chronicle - Oct 25 2014]
First reported Oct 24 2014 - Updated Oct 25 2014 - 6 reports

FDA Approves Recombinant Porcine-Sequence Factor VIII

—FDA on October 23 approved recombinant porcine-sequence antihemophilic factor, or Obizur, for the treatment of bleeding episodes in adults with acquired hemophilia A.Patients with acquired hemophilia A, the agency said, produce coagulation factor VIII ... [Published ASHP - Oct 25 2014]
First reported Oct 24 2014 - Updated Oct 25 2014 - 3 reports

Washington Biotechnology & Biomedical Association Release: Governor Joins Washington???s Life Science Industry To Celebrate 25 Years Of Life-Changing Innovation

SEATTLE--(BUSINESS WIRE)--Today, the Washington Biotechnology & Biomedical Association (WBBA) is recognizing its 25th year as an organization at the Governor’s Life Sciences Summit & Annual Meeting. During the event, Governor Jay Inslee will address the ... [Published BioSpace - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 34 reports

Millions of doses by 2015 end

Millions of doses of an experimental Ebola vaccine will be produced by the end of 2015, the World Health Organisation has announced.It said "several hundred thousand" would be produced in the first half of the year.And vaccines could be offered to health ... [Published Bangladesh Daily Star - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 5 reports

Bristol-Myers Squibb's (BMY) CEO Lamberto Andreotti on Q3 2014 Results - Earnings Call Transcript

OperatorGood day, and welcome to today's Third Quarter 2014 Earnings Conference Call. This call is being recorded. At this time, I would like to turn the call over to John Elicker. Please go ahead, sir.John E. ElickerThanks, Travis. Good morning, everybody, ... [Published Seeking Alpha - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 12 reports

Market report: AstraZeneca slips on Pfizer buy back

Citigroup said a bid for the drugmaker was still possible despite the Pfizer cash return ... [Published Yahoo! Finance UK and Ireland - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 5 reports

Shire posts sharp rises in sales and earnings for third-qtr

Ireland-headquartered Shire (LSE: SHP) has delivered a strong set of financials for the third-quarter of 2014, validating its strong prospects as a standalone pharma company following the termination of the planned $54 billion acquisition by the USA’s ... [Published Pharma Letter - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 4 reports

GENZYME : BioMarin Announces Third Quarter 2014 Financial Results

Non-GAAP net loss was $22.9 million , or $0.16 per basic and diluted share for the third quarter of 2014, compared to non-GAAP net loss of $16.7 million for the third quarter of 2013. For the nine months ended September 30, 2014 , non-GAAP net loss was ... [Published 4 Traders - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 11 reports

EMA favors AstraZeneca's ovarian cancer drug Lynparza that FDA committee dissed

An FDA committee of experts this summer voted overwhelmingly against approval of AstraZeneca's ( $AZN ) new ovarian cancer treatment, which it will market as Lynparza. But reviewers for the EMA like it enough to give it a recommendation nod for use on ... [Published FiercePharma - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 3 reports

How Regeneron Is Benefiting From Continued Sanofi Investments

Developing drugs is expensive. Just ask executives at Regeneron Pharmaceuticals Inc., a New York-based drug developer. They will describe the high-risk and high-reward world of bringing a drug to market. They will also outline an emerging trend among ... [Published BioSpace - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 11 reports

Hikma Pharma shares slip on FDA warning for Portugal plant (Reuters)

(Reuters) - Drugmaker Hikma Pharmaceuticals Plc said the U.S. health regulator had raised issues related to environmental monitoring at its plant in Portugal, which some analysts said ac... ... [Published Yahoo! News Australia - Oct 24 2014]


"But as a general matter, warning letter recipients who fail to make adequate corrections are subject to enforcement actions such as seizure and injunction."
AAW Chairman and CEO, Faisal Abdulwahab Ali Al-Mutawa said: "Our investment is to help grow and expand pharmacies in the different communities across Kuwait especially inline with the growing population in Kuwait. By partnering with co-operative pharmacies, we aim to ensure every neighborhood is offered a pharmacy, operated by professional pharmacists so that medical products and equipment are close-by and at hands-reach."
"Such mandatory labeling could imply that food products containing these ingredients are somehow inferior to their conventional or organic counterparts" said the GM crop producer
...In a recent profile for the Colorado Springs Gazette's Leading Lawyers' issue on August 24, 2014, Pat Marrison said, "Too often clients are engaged in battle, instead of living life. We can help clients get through their case with grace and efficiency so that they can get back to enjoying their children, homes, and new opportunities."

More Content

All (32216) | News (31913) | Reports (1) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (28)
sort by: Date | Relevance
Health Canada concerned about vaccine plant [Published Comox Valley Record - 5 mins ago]
SRI International opens facility for human clin... [Published Crains Detroit Business - 31 mins ago]
AAW Pharmaceuticals continues expansion in Kuwa... [Published - 32 mins ago]
Update: AstraZeneca Receives Positive EMA Recom... [Published Seeking Alpha - 45 mins ago]
Rite Aid and CVS Pharmacies Block Apple Pay [Published IClarified - 52 mins ago]
Coca-Cola, Pepsi give $1 million each to oppose... [Published Natural News - 1 hour ago]
Patricia Marrison Named in Top 100 Lawyers by T... [Published BioSpace - 1 hour ago]
Alzheimer's Drug Discovery Foundation Invites L... [Published Philanthropy News Digest - 2 hours ago]
View from the Street: Shorten stands up for som... [Published WA Today - 2 hours ago]
Merck and TAP Biosystems Chosen as Finalists fo... [Published Advance for Administrators of the Laboratory - 2 hours ago]
Biometric Voting During Brazilian Runoff Elections [Published The Rio Times - 2 hours ago]
Celgene, Sutro Biopharma broaden relationship w... [Published Drug Discovery News - 3 hours ago]
Decoding giftedness: journey to excellence [Published Rappler - 4 hours ago]
St. Jude researchers find that experimental bre... [Published Noodls - 6 hours ago]
Pharmacological inhibition of O-GlcNAcase (OGA)... [Published 7thSpace - 6 hours ago]
Rain waters down pharmaceutical disposal take-back [Published Woodland Daily Democrat - 6 hours ago]
Concerns In Agricultural Biotechnology (1) [Published The Guardian Nigeria - 7 hours ago]
Data sharing efforts to promote genomic medicine [Published PHG Foundation - 7 hours ago]
Presence or absence of public servants: biometr... [Published Business Recorder - 7 hours ago]
Johnson & Johnson to Work on Ebola Vaccine and ... [Published American Banking News - Forex - 8 hours ago]
10/26/2014: Front Page: PM deadline for biometr... [Published Hindustan Times - 8 hours ago]
Dutton adds new medicines to Pharmaceutical Ben... [Published Daily News - 8 hours ago]
Spectrophotometer Software is Compliant to Inte... [Published Labmate Online - 8 hours ago]
Nurse Criticizes Newark Airport Treatment Amid ... [Published Washington Post - 9 hours ago]
Barriers to the implementation of mobile phone ... [Published 7thSpace - 9 hours ago]
Baker, Coakley weigh in on the Mass. economy [Published Boston Globe - 9 hours ago]
Three-year clinical outcome of patients with bi... [Published American Heart Journal - 9 hours ago]
Drugs make cancer survivable, but it's not plea... [Published Woodland Daily Democrat - 9 hours ago]
Bestway Group completes Co-operative’s pharma b... [Published Qatar Peninsula - 9 hours ago]
Label GMOs [Published Dalles Chronicle - 10 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
Content Volume
Document Volume


sort by: Date | Relevance
From Sprint And TechStars To The FDA, A Look At... [Published TechCrunch - Oct 10 2013]
The health-care industry in the U.S. is broken, and considering the industry itself represents some 18 percent of the U.S. economy, it’s a sizable problem. While other sectors have begun to adapt, health care has managed to resist change — particularly ...

Press Releases

sort by: Date | Relevance
Using genomics to make personalized, safer medi... [Published PR Newswire - Feb 03 2014]
Endo Completes Acquisition of Specialty Generic... [Published PR Newswire - Feb 03 2014]
10 Reasons Why Biometric Exit May Advance in 2014 [Published PR Newswire - Feb 03 2014]
Regado Biosciences Announces $20 Million Privat... [Published PR Newswire - Jan 31 2014]
Novo Nordisk Promotes Eddie Williams to Senior ... [Published PR Newswire - Jan 30 2014]
1 2 3 4 5 6
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.